The principals behind the federal Operation Warp Speed initiative expressed optimism yesterday that the Food and Drug Administration could soon authorize two safe and highly effective COVID-19 vaccines. The panel said it expects approximately 40 million doses of the two vaccine candidates to be available for distribution in the U.S. by the end of December.

"Production, of course, would continue to ramp up after that," said Health and Human Services Secretary Alex Azar, noting that, in addition to supporting the development of vaccine candidates, Operation Warp Speed is focused on the allocation, distribution, administration and ongoing monitoring and data work for approved vaccines.

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…